4//SEC Filing
YANCOPOULOS GEORGE 4
Accession 0001883850-24-000033
CIK 0000872589other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:10 PM ET
Size
8.3 KB
Accession
0001883850-24-000033
Insider Transaction Report
Form 4
YANCOPOULOS GEORGE
DirectorEVP CSO & Pres Regn Res Labs
Transactions
- Gift
Common Stock
2024-06-10−75,799→ 0 total(indirect: by 2022 GRAT II) - Gift
Common Stock
2024-06-10+37,900→ 56,048 total(indirect: By Children)
Holdings
- 180,000(indirect: By Trust)
Common Stock
- 5,903(indirect: By 401(k))
Common Stock
- 868,994
Common Stock
Footnotes (1)
- [F1]As investment trustee of trusts for the benefit of the reporting person's children.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001226690
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:10 PM ET
- Size
- 8.3 KB